1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Psiquiátricas

Enfermedades Psiquiátricas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gassó P, Mas S, Bioque M, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Sarró S, Mané A, Sanjuan J, Llerena A, Lafuente A, Saiz-Ruiz J, Bernardo M, PEPs Group.

    Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.

    JOURNAL OF PSYCHOPHARMACOLOGY . 32(6): 702-710. Nº de citas: 4

    [doi:10.1177/0269881118773026]

  • Alvarez-Mon MA, Asunsolo Del Barco A, Lahera G, Quintero J, Ferre F, Pereira-Sanchez V, Ortuño F, Alvarez-Mon M.

    Increasing Interest of Mass Communication Media and the General Public in the Distribution of Tweets About Mental Disorders: Observational Study.

    JOURNAL OF MEDICAL INTERNET RESEARCH . 20(5): . Nº de citas: 19

    [doi:10.2196/jmir.9582]

  • Bioque M, García-Portilla MAP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Gutiérrez-Fraile M, Rodriguez-Jimenez R, Mezquida G, Llerena A, Saiz-Ruiz J, Bernardo M, PEPs GROUP.

    Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

    SCHIZOPHRENIA RESEARCH . 193: 188-196. Nº de citas: 27

    [doi:10.1016/j.schres.2017.06.032]

  • Vieta E, Montes JM.

    A Review of Asenapine in the Treatment of Bipolar Disorder.

    CLINICAL DRUG INVESTIGATION . 38(2): 87-99. Nº de citas: 15

    [doi:10.1007/s40261-017-0592-2]

  • López-Díaz Á, Lara I, Lahera G.

    Is the Prevalence of the Deficit Syndrome in Schizophrenia Higher than Estimated? Results of a Meta-Analysis.

    PSYCHIATRY INVESTIGATION . 15(1): 94-98. Nº de citas: 9

    [doi:10.4306/pi.2018.15.1.94]

  • Brañas A, Barrigón ML, Lahera G, Canal-Rivero M, Ruiz-Veguilla M.

    Influence of depressive symptoms on distress related to positive psychotic-like experiences in women.

    PSYCHIATRY RESEARCH . 258: 469-475. Nº de citas: 5

    [doi:10.1016/j.psychres.2017.08.094]

  • Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J, PEPs Group.

    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.

    JOURNAL OF CLINICAL PSYCHIATRY . 78(9): 1414-1422. Nº de citas: 20

    [doi:10.4088/JCP.16m11122]

  • Bernardo M, Bioque M, Cabrera B, Lobo A, González-Pinto A, Pina L, Corripio I, Sanjuán J, Mané A, Castro-Fornieles J, Vieta E, Arango C, Mezquida G, Gassó P, Parellada M, Saiz-Ruiz J, Cuesta MJ, Mas S, PEPs GROUP.

    Modelling gene-environment interaction in first episodes of psychosis.

    SCHIZOPHRENIA RESEARCH . 189: 181-189. Nº de citas: 30

    [doi:10.1016/j.schres.2017.01.058]

  • Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M, PEPs Group.

    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

    SCHIZOPHRENIA RESEARCH . 189: 84-90. Nº de citas: 24

    [doi:10.1016/j.schres.2017.01.047]

  • Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J, Vieta E.

    Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(10): 959-969. Nº de citas: 9

    [doi:10.1016/j.euroneuro.2017.08.429]

  • Lahera G, Ruiz A, Brañas A, Vicens M, Orozco A.

    Reaction time, processing speed and sustained attention in schizophrenia: impact on social functioning.

    REVISTA DE PSIQUIATRIA Y SALUD MENTAL . 10(4): 197-205. Nº de citas: 20

    [doi:10.1016/j.rpsm.2017.04.001]

  • Andrade-González N, Lahera G, Fernández-Liria A.

    Patient-Therapist Perspective of the Working Alliance in Psychotherapy.

    PSYCHIATRIC QUARTERLY . 88(3): 623-633. Nº de citas: 3

    [doi:10.1007/s11126-016-9477-4]

  • Varo C, Jimenez E, Solé B, Bonnín CM, Torrent C, Valls E, Morilla I, Lahera G, Martínez-Arán A, Vieta E, Reinares M.

    Social cognition in bipolar disorder: Focus on emotional intelligence.

    JOURNAL OF AFFECTIVE DISORDERS . 217: 210-217. Nº de citas: 19

    [doi:10.1016/j.jad.2017.04.012]

  • Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J, Menchón JM.

    Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.

    Bmc Psychiatry . 17(1): 250-250. Nº de citas: 107

    [doi:10.1186/s12888-017-1412-1]

  • Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group.

    Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(7): 647-656. Nº de citas: 7

    [doi:10.1016/j.euroneuro.2017.03.012]

  • Cariaga-Martinez A, Paz RA.

    Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 18(4): . Nº de citas: 7

    [doi:10.3390/ijms18040790]

  • Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, Arango C, Jimenez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Vieta E, Martinez-Aran A, Torrent C, CIBERSAM Functional Remediation Group.

    Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(4): 350-359. Nº de citas: 16

    [doi:10.1016/j.euroneuro.2017.01.010]

  • Mané A, Bergé D, Penzol MJ, Parellada M, Bioque M, Lobo A, González-Pinto A, Corripio I, Cabrera B, Sánchez-Torres AM, Saiz-Ruiz J, Bernardo M.

    Cannabis use, COMT, BDNF and age at first-episode psychosis.

    PSYCHIATRY RESEARCH . 250: 38-43. Nº de citas: 14

    [doi:10.1016/j.psychres.2017.01.045]